Skip to content

Adult attachment and affect regulation in personality disorder

Adult attachment and affect regulation in personality disorder - Attachment and affect regulation in personality disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34480
Enrollment
205
Registered
2010-10-14
Start date
2011-03-20
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

personality disorder

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All female patients in psychotherapeutic treatment at the department of Psychotherapy of the Riagg Rijnmond are invited to participate in the study and to enter the additional diagnostic procedures after full verbal and written informed consent. Selection of controls: based on medical history information and present state physical and mental condition (established by the intake-interview and questionnaire), the subjects must be in good health, and without a history of psychiatric illness. The control subjects must be drug-free at the time of the study.

Exclusion criteria

Exclusion criteria: Patients with a history of schizophrenia or bipolar disorder, current substance or alcohol abuse, or the use of cortisone or psychotropic medication will be excluded from the study. Also, patients who are visual disabled, with neurological, cardiovascular or respiratory diseases and those who do not sufficiently master the Dutch language or who have clinically relevant low IQ will be excluded.

Design outcomes

Primary

MeasureTime frame
primary study parameters: score attachment related anxiety and avoidance; subjective labeling of emotional pictures; heart rate and skin conductance response to stress; cortisol and oxytocine response to stress.

Secondary

MeasureTime frame
n.v.t.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)